A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
Clinical trial NCT03862430 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03862430
- Sponsor
- NuvOx LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2027-06-30
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.